Articles

ATMP Potency Assay Strategies: Adding Value to Your Asset and Avoiding Delays in Development

This white paper discusses the value of planning potency assays early in the clinical development process, explains some of the barriers to potency assay development and regulatory acceptance and provides some top tips on how to overcome potential hurdles.

Filed In

Articles
Pharma
Phase I & FIH
Stage (Early, PhI-IIa)
Stage (Late, PhIIb-III)
Therapies - Cell
Therapies - Gene